LIPID ELONGATION VIA ELOVL5: A NOVEL TARGET FOR ADVANCED PROSTATE CANCER...NEW GRANT, SIGNED 9/16/2019, EFFECTIVE 9/30/2019, DISTRIBUTED 9/17/2019, FAADC 9/17/2019
$736,816FY2019Defense Health AgencyDOD
Weill Medical College Of Cornell University
Weill Medical College Of Cornell University